ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma

Sun, Zihao; Chen, Xiujing; Huang, Xiaoning; Wu, Yanfen; Shao, Lijuan; Zhou, Suna; Zheng, Zhu; Lin, Yiguang*; Chen, Size*广东药学院; 1
Life-Basel2023-7DOI: 10.3390/life13071583
8阅读
引用收藏
分享

摘要

Cuproptosis and associated immune-related genes (IRG) have been implicated in tumorigenesis and tumor progression. However, their effects on lung adenocarcinoma (LUAD) have not been elucidated. Therefore, we investigated the impact of cuproptosis-associated IRGs on the immunotherapy response and prognosis of LUAD using a bioinformatical approach and in vitro experiments analyzing clinical samples. Using the cuproptosis-associated IRG signature, we classified LUAD into two subtypes, cluster 1 and cluster 2, and identified three key cuproptosis-associated IRGs, NRAS, TRAV38-2DV8, and SORT1. These three genes were employed to establish a risk model and nomogram, and to classify the LUAD cohort into low- and high-risk subgroups. Biofunctional annotation revealed that cluster 2, remarkably downregulating epigenetic, stemness, and proliferation pathways activity, had a higher overall survival (OS) and immunoinfiltration abundance compared to cluster 1. Real-time quantitative PCR (RT-qPCR) validated the differential expression of these three genes in both subgroups. scRNA-seq demonstrated elevated expression of NRAS and SORT1 in macrophages. Immunity and oncogenic and stromal activation pathways were dramatically enriched in the low-risk subgroup, and patients in this subgroup responded better to immunotherapy. Our data suggest that the cuproptosis-associated IRG signature can be used to effectively predict the immunotherapy response and prognosis in LUAD. Our work provides enlightenment for immunotherapy response assessment, prognosis prediction, and the development of potential prognostic biomarkers for LUAD patients.

学科与关键词

关键词
cuproptosislung adenocarcinomaIRGsprognosistumor microenvironment
相关
加载中…
  • Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
    Lv, Yanju; Xiao, Yajie; Cui, Xiaoli; Luo, Haitao*; Xu, Long*Frontiers in Genetics, 2022, 13: 1016871.被引 3
  • A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
    Yu, Sheng; Tang, Lingxue; Zhang, Qianqian; Li, Wen; Yao, Senbang; Cai, Yinlian; Cheng, Huaidong*HEREDITAS, 2023, 160(1): 31.被引 2
  • Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
    Kuang, Junjie; Zheng, Zemao; Ma, Wen; Zeng, Shaohui; Wu, Dehua*; Weng, Xie*; Chen, Yuming*Frontiers in Pharmacology, 2023, 14: 1240736.
查看全部 →

发表信息

论文状态
公开发表
期刊
Life-Basel
发表日期
2023-07
卷期
第 13 卷, 第 7 期
页码
1583
DOI
10.3390/life13071583
成果收录
SCIE
资助标注
Guangdong Science and Technology Department [2020A0505100058]; Department of Education of Guangdong Province [2019KZDXM024]; Guangdong Province Medical Products Administration [2022TDZ19]

作者

  • S

    Sun, Zihao (第一作者)

    1 · guangdong pharmaceut univ

  • C

    Chen, Xiujing

    1 · guangdong pharmaceut univ

查看全部 9 位作者收起作者
  • H

    Huang, Xiaoning

    1 · guangdong pharmaceut univ

  • W

    Wu, Yanfen

    1 · guangdong pharmaceut univ

  • S

    Shao, Lijuan

    1 · guangdong pharmaceut univ

  • Z

    Zhou, Suna

    1 · guangdong pharmaceut univ

  • Z

    Zheng, Zhu

    1 · guangdong pharmaceut univ

  • L

    Lin, Yiguang (通讯)

    1 · guangdong pharmaceut univ

  • C

    Chen, Size (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417